
Knowledge Nugget: Global Tobacco Epidemic 2025 report – Must know insights for UPSC Exam
(Relevance: Global reports released by international organisations such as the WHO are highly relevant for the UPSC exam, as they present a comprehensive image of various issues and India's position with respect to other countries.)
Tobacco use remains one of the gravest public health threats the world has ever faced, claiming over eight million lives annually. Of these, more than seven million deaths result from direct tobacco use, according to the Global Burden of Disease study by the Institute for Health Metrics and Evaluation (IHME).
For tackling the challenge of high tobacco consumption, health warnings are an effective way to help people quit tobacco use. In this context, knowing the key highlights of the World Health Organisation's Global Tobacco Epidemic 2025 report, which focuses on measures to warn people about the harms of tobacco, becomes important.
1. The Global Tobacco Epidemic 2025 report is developed by WHO with support from Bloomberg Philanthropies. It focuses on six proven WHO MPOWER tobacco control measures to reduce tobacco use.
2. The WHO Framework Convention on Tobacco Control (WHO FCTC) and its guidelines provide the foundation for countries to implement and manage tobacco control. To help make this a reality, WHO introduced the MPOWER measures.
3. MPOWER measures are intended to assist in the country-level implementation of effective interventions to reduce the demand for tobacco, contained in the WHO FCTC. MPOWER measures are –
📌M– monitor tobacco use and prevention policies;
📌P– protect people from tobacco smoke;
📌O– offer help to quit tobacco;
📌W– warn about dangers of tobacco;
📌E– enforce bans on tobacco advertising; and
📌R– raise taxes on tobacco products.
4. A total of 110 countries now require these measures — up from just nine in 2007 — protecting 62 per cent of the global population; and 25 countries have adopted plain packaging.
1. The 2025 report focuses on the W measure (warn about the dangers of tobacco) and shows that with 6.1 billion people protected by at least one MPOWER measure at best-practice level many countries continue to make progress in the fight against tobacco.
Health warnings and mass media campaigns work best when they are part of a comprehensive tobacco control strategy.-WHO
2. Four countries have now achieved the full MPOWER packaged while a further seven are only one measure away. At the same time 40 countries still have no MPOWER measure at best-practice level.
3. The report reveals that the most striking gains have been in graphic health warnings, one of the key measures under the WHO FCTC.
4. According to the report, India is among the countries identified as having best-practice-level graphic health warning labels in 2024.
5. Of all MPOWER measures, large graphic health warnings on cigarette packages have seen the most progress since 2007 – both in terms of the number of countries and population covered by a best-practice policy. Not only are more countries adopting graphic health warnings, but the average size of warnings has increased from 28 per cent in 2007 to almost 60 per cent in 2024.
India has achieved the highest status in O and W (both in 2016) and is in the second highest category of other measures, including M (mass media). Health warnings on cigarette packs are among the largest in the world at 85 per cent. Only 10 countries have a larger graphic health warning. – Dr Vinayak Mohan Prasad (head of the Global Tobacco Control Programme)
6. On the ˋW' measure, India has been in the highest group since 2016. On the 'E' measure, India has banned direct and indirect tobacco advertising, promotion and sponsorships
7. The WHO report also warned that action is needed to maintain and accelerate progress in tobacco control as rising industry interference challenges tobacco policies and control efforts.
8. Notably, Tobacco tax is least adopted MPOWER measure in India.
1. India is among the six countries that received 2025 Bloomberg Philanthropies Awards for Global Tobacco Control for prioritizing tobacco cessation approaches to reach a significant number of tobacco users in the country.
2. The National Tobacco Control Cell of Ministry of Health and Family Welfare, Government of India, was presented with the award at the World Conference on Tobacco Control held in Dublin, Ireland, on Monday (23rd June).
3. India was presented the 'O' category award for promoting tobacco cessation. Among the other countries that received the award were Mauritius, Mexico, Montenegro, Philippines and Ukraine.
1. India has implemented stringent measures to curb tobacco advertising, promotion and sponsorship (TAPS) across all forms of media, including television, radio, print and digital platforms.
2. To restrict depiction of tobacco use in entertainment media, the Centre introduced the Tobacco-Free Films and Television Rules in 2012, focusing on traditional platforms such as cinema and television.
3. As more people shift towards using digital streaming platforms, India recognized the need to update its tobacco control policies. Coinciding with World No Tobacco Day on May 31, 2023, the government introduced an amendment to the 2012 legislation, extending its coverage to over-the-top streaming platforms. With this move, India became the first country in the world to apply tobacco control regulations specifically to digital streaming content.
4. The WHO report said that India is reinforcing its commitment to public health and positioning itself as a pioneer in adapting regulation to evolving media consumption trends. However, the current national TAPS ban can be further strengthened by prohibiting tobacco advertising at points of sale and fully banning tobacco industry sponsorship.
1. Despite widespread awareness of tobacco's health risks, the raw tobacco industry continues to thrive. In 2022, an estimated 5.8 million tonnes of tobacco were produced globally, with China accounting for roughly one-third of this output, according to Statista.
2. In the same year, India and Brazil produced approximately 0.8 million and 0.7 million tonnes of unmanufactured tobacco respectively, according to the UN's Food and Agriculture Organisation (FAO).
3. The world's top 10 largest Tobacco producing countries, as of 2023 are:
Source: United Nations' Food and Agriculture Organisation (UN FAOSTAT)
4. Notably, India is the world's second-largest producer and consumer of unmanufactured tobacco, with a production volume of nearly 770,000 tonnes.
Consider the following statements:
1. The theme for World No Tobacco Day 2025 is 'Protecting children from tobacco industry interference.'
2. India is the world's largest producer and consumer of unmanufactured tobacco.
Which of the statements given above is/are correct?
(a) 1 only
(b) 2 only
(c) Both 1 and 2
(d) Neither 1 nor 2
(Sources: India conferred with Bloomberg Philanthropies Awards for Global Tobacco Control, Top 10 largest tobacco-producing countries: India ranks among top 3, India scores high in graphic health warnings, cessation bans: WHO report on global tobacco use)
Subscribe to our UPSC newsletter. Stay updated with the latest UPSC articles by joining our Telegram channel – Indian Express UPSC Hub, and follow us on Instagram and X.
🚨 Click Here to read the UPSC Essentials magazine for June 2025. Share your views and suggestions in the comment box or at manas.srivastava@indianexpress.com🚨
Roshni Yadav is a Deputy Copy Editor with The Indian Express. She is an alumna of the University of Delhi and Jawaharlal Nehru University, where she pursued her graduation and post-graduation in Political Science. She has over five years of work experience in ed-tech and media. At The Indian Express, she writes for the UPSC section. Her interests lie in national and international affairs, governance, economy, and social issues. You can contact her via email: roshni.yadav@indianexpress.com ... Read More
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Mint
8 hours ago
- Mint
Drugs regulator to turn the screws on spurious medical products
New Delhi: India's apex drug regulator—-Central Drugs Standard Control Organisation (CDSCO)—is developing a comprehensive national action plan to combat substandard and spurious medical products, officials and documents said. This follows a World Health Organization (WHO) assessment that highlighted major areas for improvement needed in India's drug regulatory framework. The proposed action plan in the works will implement new prevention, detection and response strategies at both central and state levels. A key focus will be on strengthening the surveillance and control of medical product advertisements aimed at healthcare professionals. The WHO recommended enhanced training and stricter oversight to ensure that all promotional, marketing, and advertising materials provide accurate and non-misleading information about medical products. Further, the CDSCO plans to mandate that all central and state authority websites feature a dedicated reporting page for sub-standard and falsified (spurious) products. Tighter rules for drug ads and easier reporting for public 'As part of the plan, a core component of the CDSCO's revamped approach will be the strengthening of surveillance and control over medical product advertisements, particularly those targeting healthcare professionals. Keeping a closer eye on medical product advertisements will help patients in getting accurate information, safer treatment choices, reduce the dangers of self medication, and better doctor-patient conversations. As per Indian regulations, companies cannot make advertisements of drugs following in schedule H, H1 and X. These drugs are controlled and sold in the prescription of registered medical practitioners," an official said. 'The proposal for implementation of WHO's recommendations were discussed in the Drugs Consultative Committee meeting last month chaired by the Drugs Controller General of India (DCGI). It was agreed upon to take suitable action for each of the recommendations," the official said. Tracking suprious and substandard drugs Notably, one of the important WHO's recommendations is to combat the menace of spurious and sub-standard drugs: preventing, detecting, and responding to "not of standard quality" and "spurious medical drugs," alongside a robust market surveillance program and stringent control over promotional, marketing and advertising activities. The WHO has recommended that all Central and State government websites provide a dedicated 'substandard and falsified (SF) reporting page - with information for the public on how to specifically report SF products. Reports from this mechanism should be subject to the SF report handling procedure for that organization. 'This is an important step towards increased transparency and public participation in identifying or reporting the SF products. This will empower the public to directly report suspicious products and these reports will then be properly investigated," said the official, adding that a communication from DCGI may shortly be released to all the States/UTs to implement the action points in a uniform manner. 'The government is also doing risk-based assessment of pharma firms to keep a track on the drug manufacturing and actions have also been taken," the official said. The Indian pharmaceutical market is set to reach$100 billion by 2025, as per government is the largest provider of generic drugs globally and is also known for its affordable vaccines. 'These measures will not only help protect patients but also safeguard the integrity of compliant pharmaceutical companies," said Nikkhil K. Masurkar, chief executive officer, Entod Pharmaceuticals. Masurkar said that when a spurious or falsified version of a company's drug appears in the market, it triggers significant challenges, even when the original manufacturer has followed all regulatory protocols. 'Patient safety becomes the immediate concern, but the ripple effects are far-reaching. The company can face public scepticism, reputational damage, and erosion of trust among healthcare providers, all because a counterfeit product misrepresents their brand. What makes it more difficult is that the manufacturer is often unfairly perceived as responsible, even when the fault lies entirely with external bad actors. The company is then forced to redirect time, resources, and focus towards legal action, crisis communication, and internal audits, diverting energy from innovation and patient engagement. Despite being the victim, the brand often suffers disproportionately, with long-term reputational impact that's hard to undo." Queries sent to the health ministry spokesperson and WHO remained unanswered.


Deccan Herald
11 hours ago
- Deccan Herald
Nipah patient critical in Kerala's Palakkad; containment zone declared
Nipah virus infection, according to the WHO website, is a zoonotic illness that is transmitted to people from animals, and can also be transmitted through contaminated food or directly from person to person.


Time of India
12 hours ago
- Time of India
Experts call for integration of Physical Medicine and Rehabilitation into standard stroke care
New Delhi: On the occasion of National Physical Medicine and Rehabilitation (PMR) Day, neurologists and rehabilitation experts in the national capital called for urgent integration of Physical Medicine and Rehabilitation into India's stroke care protocols. With stroke now the second leading cause of death and the third leading cause of disability in the country, doctors stressed that rehabilitation within the first 90 days is essential - not just for survival but for full functional recovery. "Stroke is a race against time, not just during the attack, but long after hospital discharge," said Dr Man Mohan Mehndiratta, Principal-Director and Senior Consultant, Neurology, BLK-Max Centre for Neurosciences. "While emergency response has improved through ACT FAST awareness, post-stroke recovery remains poorly structured. Without targeted rehabilitation, patients may survive but lose their independence, speech, or memory," Dr Mehndiratta said. Stroke is increasingly affecting younger people in urban centres like Delhi, fueled by rising rates of hypertension, chronic stress and sedentary lifestyles. According to the India Hypertension Control Initiative (ICMR-WHO, 2023), one in four Indian adults is hypertensive, yet only 12 per cent have it under control. Experts are now calling for broader adoption of Physical Medicine and Rehabilitation (PMR), a multidisciplinary medical speciality that supports recovery after stroke, spinal cord injuries and head trauma. PMR combines robotic-assisted therapy, speech and occupational therapy, cognitive retraining and psychological support, all under a structured, evidence-based roadmap led by rehabilitation physicians. "Rehabilitation is not just exercise. It's a guided, clinical process," said Dr Amit Tomar, Lead Consultant - PMR, HCAH (HealthCare atHOME) said. "The brain's plasticity is highest in the first three months post-stroke. "Every day of delay narrows the window for recovery," he said. In a recent HCAH survey, only 40 per cent of respondents could identify stroke symptoms before hospitalisation. Yet among patients who received structured inpatient rehabilitation , 92 per cent regained core functional abilities within three months. In contrast, 70 per cent of those on unstructured home care took over four months to regain basic functions like speech and mobility. "These numbers reinforce the importance of timely, specialist-led rehab," said Dr Gaurav Thukral, Co-founder and Chief Operating Officer, HCAH. As stroke cases rise, experts called on national and state health authorities to take bold action to embed PMR into every stroke treatment protocol, expand insurance coverage for inpatient rehab, train more PMR specialists and rehab teams and establish dedicated neuro-rehabilitation centres in both public and private healthcare systems. "Survival should not be the end goal. Recovery with dignity must become the new standard," said Dr Mehndiratta. PTI